Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and changing regulatory requirements by expanding its portfolio of TPO-free light-curable materials.

Preemptive Compliance and Long-Term Readiness

In anticipation of the European Union legislative changes on Trimethylbenzoyl Diphenylphosphine Oxide (TPO) and in response to growing consumer concerns around the world, Dymax is expanding our portfolio of TPO-free formulations designed to meet evolving safety standards and support long-term product design and planning.

The available TPO-free products have been rigorously tested to deliver the performance and quality characteristics expected of all Dymax chemistries. For medical device applications, adhesives meet biocompatibility standards, including ISO 10993-5 cytotoxicity and others as appropriate, helping support internal validation or documentation requirements. Additionally, manufacturers who want to integrate the formulations into existing production environments can seek assistance from Dymax technical service specialists who can help customers move confidently through validation processes with current applications or new product development efforts.

"Our commitment to monitoring and assessing the needs of the marketplace and developing innovative and effective solutions drives us to stay ahead of the marketplace," said Michael Ford, Head of Business Development at Dymax. "By enabling access to our expanded portfolio of TPO-free products early and continuing to evolve our product lines where needed, we are giving our customers the confidence to continue using our materials while meeting evolving global standards and end-user needs."

Supporting Product Transitions

Recognizing that any formulation change can raise questions, Dymax provides technical and regulatory support to help customers assess and adopt TPO-free options, including:

  • Current application product review to determine potential TPO-containing product use
  • Product Data Sheets for material property review prior to in-house validation
  • Application engineering guidance to evaluate any required process adjustments
  • Access to regulatory teams for questions about global compliance requirements

While the regulatory push is strongest in the EU, Dymax’s proactive approach will help enable a timely transition for the customer, giving them confidence in product reliability and future compliance directives while simultaneously addressing consumer needs.

Customers are encouraged to contact Dymax technical advisors to answer questions on process and design changes and for support in evaluating solutions that meet immediate performance needs and longer-term planning goals.

Über die DYMAX Europe GmbH

Dymax develops innovative rapid and light-curable materials, dispensing equipment, and UV/LED light-curing systems. The company’s adhesives, coatings, and equipment are perfectly matched to work seamlessly with each other, providing design engineers with tools to dramatically improve manufacturing efficiencies. Major markets include aerospace and defense; medical device; and consumer and automotive electronics.

For additional information on Dymax, visit www.dymax.com or call 860-482-1010.

Firmenkontakt und Herausgeber der Meldung:

DYMAX Europe GmbH
Kasteler Straße 45
65203 Wiesbaden
Telefon: +49 (611) 962-7900
Telefax: +49 (611) 962-9440
https://de.dymax.com/

Ansprechpartner:
Cindy Gallagher
Marketing Sr Communications Specialist Global
E-Mail: Cgallagher@dymax.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel